November 17, 2010 — AccuDetect 4.0 computer-aided detection (CAD) software has been released. It features performance improvements and a greater potential for lowering false-positive rates when detecting suspicious lesions on mammograms as compared to the previous version of the product.

Parascript LLC says AccuDetect 4.0 is unique in that it achieves high sensitivity and low false positive rates through the integration of several complimentary algorithms and a sophisticated voting scheme within a single CAD system.

Available for OEM customers interested in reducing false-positive rates of existing CAD systems, AccuDetect is intended to assist radiologists in the early detection of breast cancer during mammography screening exams. It is tuned to work with the leading full-field digital and computed radiography vendors. The software recently received CE Mark approval and is deployed in the European Union.

CAD systems are typically relied upon to identify and highlight hard-to-find features and anomalies on medical images that may be indicative of cancer and bring them to the attention of radiologists. AccuDetect automatically identifies and clearly marks suspicious areas without obscuring the region of interest, enabling a more accurate interpretation of mammograms and increased detection of calcifications and masses.

For more information: www.parascript.com


Related Content

News | Radiation Oncology

July 16, 2026 — Raidium has announced the U.S. launch of Raidium Read (R.Read), applying its AI-native imaging solution ...

Time July 16, 2026
arrow
News | Breast Imaging

July 7, 2026 — QT Imaging Holdings, Inc. recently announced it has successfully completed its first routine inspection ...

Time July 07, 2026
arrow
News | MRI Breast

July 2, 2026 – Quibim has announced the European and UK launch of QP-Breast, its CE and UKCA-marked AI tool which ...

Time July 02, 2026
arrow
News | Mammography

June 30, 2026 — The Food and Drug Administration has cleared new contrast-enhanced mammography (CEM) and CEM biopsy ...

Time June 30, 2026
arrow
News | Mammography

June 23, 2026 — Using artificial intelligence (AI), researchers found that image-based risk scores for breast cancer ...

Time June 24, 2026
arrow
News | FDA

June 4, 2026 — GE HealthCare has received 510(k) clearance from the United States Food and Drug Administration (FDA) for ...

Time June 05, 2026
arrow
News | Women's Health

June 2, 2026 — Results of an American College of Radiology-managed retrospective study involving 110,000 women presented ...

Time June 02, 2026
arrow
News

May 21, 2026 – Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer ...

Time May 22, 2026
arrow
News | FDA

May 6, 2026 — Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer ...

Time May 07, 2026
arrow
News | Women's Health

April 16, 2026 – GE HealthCare has expanded its collaboration with DeepHealth, Inc., a wholly-owned subsidiary of RadNet ...

Time April 20, 2026
arrow
Subscribe Now